Endoscopy 2016; 48(08): 717-722
DOI: 10.1055/s-0042-107590
Original article
© Georg Thieme Verlag KG Stuttgart · New York

High-dose omeprazole infusion compared with scheduled second-look endoscopy for prevention of peptic ulcer rebleeding: a randomized controlled trial

Philip Wai Yan Chiu
1   Department of Surgery, Prince of Wales Hospital, The Chinese University of Hong Kong, Shatin, Hong Kong
2   Institute of Digestive Disease, Faculty of Medicine, The Chinese University of Hong Kong, Shatin, Hong Kong
,
Henry Kin Ming Joeng
3   Department of Surgery, United Christian Hospital, Kwun Tong, Hong Kong
,
Catherine Lai Yin Choi
3   Department of Surgery, United Christian Hospital, Kwun Tong, Hong Kong
,
Kelvin Kam Fai Tsoi
2   Institute of Digestive Disease, Faculty of Medicine, The Chinese University of Hong Kong, Shatin, Hong Kong
4   School of Public Health, Faculty of Medicine, The Chinese University of Hong Kong, Shatin, Hong Kong
,
Kwok Hung Kwong
3   Department of Surgery, United Christian Hospital, Kwun Tong, Hong Kong
,
Siu Ho Lam
3   Department of Surgery, United Christian Hospital, Kwun Tong, Hong Kong
,
Joseph Jao Yiu Sung
2   Institute of Digestive Disease, Faculty of Medicine, The Chinese University of Hong Kong, Shatin, Hong Kong
› Author Affiliations
Further Information

Publication History

submitted 07 May 2014

accepted after revision 01 April 2016

Publication Date:
08 June 2016 (online)

Background and study aim: Previous studies have shown that both scheduled second-look endoscopy and high-dose continuous omeprazole infusion are effective in preventing peptic ulcer rebleeding. The aim of this noninferiority trial was to compare the efficacy of these two strategies for the prevention of rebleeding following primary endoscopic hemostasis.

Patients and methods: Consecutive patients who received endoscopic treatment for bleeding peptic ulcers (actively bleeding, with nonbleeding visible vessels) were randomized to two treatment groups following hemostasis. One group (second-look endoscopy group) received the proton pump inhibitor (PPI) omeprazole as an intravenous bolus every 12 hours for 72 hours and a second endoscopy within 16 – 24 hours with retreatment for persistent stigmata of bleeding. The other group (PPI infusion group) received continuous high-dose omeprazole infusion for 72 hours. Patients who developed rebleeding underwent surgery if repeat endoscopic therapy failed. The primary outcome was the rebleeding rate within 30 days after initial hemostasis. The margin for noninferiority was set at 5 %.

Results: A total of 153 patients were randomized to the PPI infusion group and 152 to the second-look endoscopy group. Rebleeding occurred within 30 days in 10 patients (6.5 %) in the PPI infusion group and in 12 patients (7.9 %) in the second-look endoscopy group (P = 0.646). Surgery was required for rebleeding in six patients from the PPI infusion group and three patients in the second-look endoscopy group (P = 0.32). Intensive care unit stay, transfusion requirements, and mortality were not different between the groups. Patients in the second-look endoscopy group were discharged 1 day earlier than those in the PPI infusion group (P < 0.001).

Conclusions: After endoscopic hemostasis, high-dose PPI infusion was not inferior to second-look endoscopy with bolus PPI in preventing peptic ulcer rebleeding.

Trial registration: ClinicalTrials.gov (NCT: 00164931).

 
  • References

  • 1 Villanueva C, Balanzo J, Torras X et al. Value of second look endoscopy after injection therapy for bleeding peptic ulcer: a prospective and randomized trial. Gastrointest Endosc 1994; 40: 34-39
  • 2 Messmann H, Schaller P, Andus T et al. Effect of programmed endoscopic followup examinations on the rebleeding rate of gastric or duodenal peptic ulcers treated by injection therapy: a prospective randomized controlled trial. Endoscopy 1998; 30: 583-589
  • 3 Saeed ZA, Cole RA, Ramirez FC et al. Endoscopic retreatment after successful initial hemostasis prevents ulcer rebleeding: a prospective randomized trial. Endoscopy 1996; 28: 288-294
  • 4 Chiu PWY, Lam CYW, Lee SW et al. Effect of scheduled second therapeutic endoscopy on peptic ulcer rebleeding: a prospective randomized trial. Gut 2003; 52: 1403-1407
  • 5 El Ouali S, Barkun AN, Wyse J et al. Is routine second-look endoscopy effective after endoscopic hemostasis in acute peptic ulcer bleeding? A meta-analysis. Gastrointest Endosc 2012; 76: 283-292
  • 6 Tsoi KK, Chan HC, Chiu PW et al. Second-look endoscopy with thermal coagulation or injections for peptic ulcer bleeding: a meta-analysis. J Gastroenterol Hepatol 2010; 25: 8-13
  • 7 Lau JYW, Sung JJY, Lee KKC et al. Effect of intravenous omeprazole on recurrent bleeding after endoscopic treatment of bleeding peptic ulcers. N Engl J Med 2000; 343: 310-316
  • 8 Sung JJ, Barkun A, Kuipers EJ et al. Intravenous esomeprazole for prevention of recurrent peptic ulcer bleeding: a randomized trial. Ann Intern Med 2009; 150: 455-464
  • 9 Bardou M, Toubouti Y, Benhaberou-Brun D et al. Meta-analysis: proton-pump inhibition in high-risk patients with acute peptic ulcer bleeding. Aliment Pharmacol Ther 2005; 21: 677-686
  • 10 Neumann I, Letelier LM, Rada G et al. Comparison of different regimens of proton pump inhibitors for acute peptic ulcer bleeding. Cochrane Database Syst Rev 2013; 6 CD007999
  • 11 Lau JYW, Sung JJY, Chan ACW et al. Stigmata of hemorrhage in bleeding peptic ulcers: an interobserver agreement study among international experts. Gastrointest Endosc 1997; 46: 33-36
  • 12 Schumi J, Wittes J. Through the looking glass: understanding non-inferiority. Trials 2011; 12: 106
  • 13 Kaplan EL, Meier P. Nonparametric estimation from incomplete observations. JASA 1958; 53: 457-481
  • 14 Moher D, Schulz KF, Altman DG. The CONSORT statement: revised recommendations for improving the quality of reports of parallel-group randomized trials. Lancet 2001; 357: 1191-1194
  • 15 Jensen DM, Pace SC, Soffer E et al. Continuous infusion of pantoprazole versus ranitidine for prevention of ulcer rebleeding: a U.S. multicenter randomized, double blind study. Am J Gastroenterol 2006; 101: 1991-1999
  • 16 van Leerdam ME, Vreeburg EM, Rauws EA et al. Acute upper GI bleeding: did anything change? Time trend analysis of incidence and outcome of acute upper GI bleeding between 1993/1994 and 2000. Am J Gastroenterol 2003; 98: 1494-1499
  • 17 Chiu PW, Ng EK, Cheung FK et al. Predicting mortality in patients with bleeding peptic ulcer after therapeutic endoscopy. Clin Gastroenterol Hepatol 2009; 7: 311-316
  • 18 Green Jr FW, Kaplan MM, Curtis LE et al. Effect of acid and pepsin on blood coagulation and platelet aggregation. A possible contributor prolonged gastroduodenal mucosal hemorrhage. Gastroenterology 1978; 74: 38-43
  • 19 Barkun AN, Bardou M, Kuipers EJ et al. International consensus recommendations on the management of patients with non-variceal upper gastrointestinal bleeding. Ann Intern Med 2010; 152: 101-113
  • 20 Jensen DM. Heat probe for hemostasis of bleeding peptic ulcers: technique and results of randomized controlled trials. Gastrointest Endosc 1990; 36 : 42-49
  • 21 Chiu PW, Ng EK. Predicting poor outcome from acute upper gastrointestinal hemorrhage. Gastroenterol Clin North Am 2009; 38: 215-230